PhaseV

United States
Panora, Iowa, United States, 02114

Company profile

PhaseV company profile

PhaseV offers AI-driven solutions that enhance clinical development for biopharma sponsors and contract research organizations (CROs). The company focuses on utilizing machine learning to streamline clinical operations, improving the processes of feasibility assessments and site selection. By providing data-driven insights, PhaseV helps clients make informed decisions that accelerate trial timelines. Their innovative approach aims to transform traditional methods in clinical research, contributing to more efficient and effective drug development. With a commitment to integrating technology into clinical trials, PhaseV plays a significant role in advancing the pharmaceutical industry's operational capabilities.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2023-01-01, Year

Headquarters

Postal code
02114
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
2
Total equity funding
$65M
Last funding
Series A / $50M / 2025-05-13
Last equity funding
Series A / $50M
Investors
7
Lead investors
4
Founders
3
Articles
45

Founders and investors

Founders

Dan GoldstaubElad BerkmanRaviv Pryluk

Lead investors

AccelEXOR N.V.Insight PartnersViola Ventures

Investors

AccelEXOR N.V.Insight PartnersLionBirdViola Ventures